1988
DOI: 10.1007/bf00314172
|View full text |Cite
|
Sign up to set email alerts
|

The role of clinical neuropsychology in the neurological diagnosis of Alzheimer's disease

Abstract: This survey on the early diagnosis of Alzheimer's disease (AD) reinstates the role of clinical neuropsychology in describing the cognitive status of AD and its evolution. The role of clinical neuropsychology is restricted to the clinical diagnosis of organic mental deterioration and its contribution to the diagnosis of AD is separate from that of neurology and neuroradiology. The frequency of a single neuropsychological disturbance in early AD patients is illustrated by our own observations.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
18
0

Year Published

1991
1991
2002
2002

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 76 publications
(21 citation statements)
references
References 156 publications
3
18
0
Order By: Relevance
“…Patients were not included in the present study if they scored below 16 on the Mini-Mental State Examination (MMSE; Folstein, Folstein, & McHugh, 1975). The patients were diagnosed as suffering from progressive cognitive deterioration due to possible or probable AD on the basis of formal criteria (Spinnler & Della Sala, 1988), which broadly correspond to those proposed by NINCDS-ADRDA (McKhann et al, 1984). All the patients fulfilled the criteria for inclusion in research studies as set forth by the Medical Research Council's Alzheimer Disease Workshop Steering Committee (Wilcock et al, 1989).…”
Section: Experiments 1 Methodsmentioning
confidence: 99%
“…Patients were not included in the present study if they scored below 16 on the Mini-Mental State Examination (MMSE; Folstein, Folstein, & McHugh, 1975). The patients were diagnosed as suffering from progressive cognitive deterioration due to possible or probable AD on the basis of formal criteria (Spinnler & Della Sala, 1988), which broadly correspond to those proposed by NINCDS-ADRDA (McKhann et al, 1984). All the patients fulfilled the criteria for inclusion in research studies as set forth by the Medical Research Council's Alzheimer Disease Workshop Steering Committee (Wilcock et al, 1989).…”
Section: Experiments 1 Methodsmentioning
confidence: 99%
“…Any meaningful comparison of neuropsychological profiles must ensure that each cognitive domain be assessed on an equivalent scale. Spinnler and Della Sala [12], the first to address this issue, developed a procedure for comparing performance across tests by deriving 'grade' scores (a 5-point scale) by reference to the percentile distribution of scores of a standardisation sample. Fox et al [13] extended this methodology to derive an overall measure of severity.…”
Section: Introductionmentioning
confidence: 99%
“…The choice of 5 points was arbitra ry; T , '2' and '3' are intermediate scores between '0' and '4' on a quasi-interval scale calculated with refer ence to the normal distribution. The 'equivalent-score system' made it possible to obtain a standardized mea sure of an individual's ability and allowed us to com pare performances across all tests, irrespective of dif ferences arising from variations in test difficulty [12,13], All three scores (raw, adjusted, and equivalent) were reported on the forms given to the raters. Table 1 shows the number of patients who underwent these tests and the distribution of equivalent scores, grouped according to the type of test.…”
Section: Neuropsychological Testingmentioning
confidence: 99%